• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振和经胸超声心动图评估二尖瓣反流:系统评价和荟萃分析。

Evaluation of mitral regurgitation by cardiac magnetic resonance and transthoracic echocardiography: a systematic review and meta-analysis.

机构信息

Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Evidence-based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina, 45110 Ioannina, Greece.

出版信息

Rev Cardiovasc Med. 2021 Dec 22;22(4):1513-1521. doi: 10.31083/j.rcm2204155.

DOI:10.31083/j.rcm2204155
PMID:34957790
Abstract

Transthoracic echocardiography (TTE) and Cardiac Magnetic Resonance (CMR) have complementary roles in the severity grading of mitral regurgitation (MR). Our objective was to systematically review the correlation of MR severity as assessed by TTE and CMR. We searched MEDLINE and Cochrane Library for original series published between January 1st, 2000 and March 23rd, 2020. We used Cohen's kappa coefficient to measure agreement between modalities. We plotted a hierarchical summary receiver operator characteristic (HSROC) curve and estimated the area under the curve (AUC) to assess the concordance between the two imaging modalities for the detection of severe MR. We identified 858 studies, of which 65 underwent full-text assessment and 8 were included in the meta-analysis. A total of 718 patients were included (425 males, 59%) in the final analysis. There was significant heterogeneity in the methods used and considerable variation in kappa coefficient, ranging from 0.10 to 0.48. Seven out of eight studies provided the necessary data to plot HSROC curves and calculate the AUC. The AUC for detecting severe MR was 0.83 (95% CI 0.80 to 0.86), whereas the AUC for detecting moderate to severe MR was 0.83 (95% CI 0.79 to 0.86). The agreement between TTE and CMR in MR severity evaluation is modest across the entire spectrum of severity grading. However, when focusing on patients with at least moderate MR the concordance between TTE and CMR is very good. Further prospective studies comparing hard clinical endpoints based on the CMR and TTE assessment of MR severity are needed.

摘要

经胸超声心动图(TTE)和心脏磁共振(CMR)在二尖瓣反流(MR)严重程度分级中具有互补作用。我们的目的是系统地回顾 TTE 和 CMR 评估的 MR 严重程度之间的相关性。我们在 MEDLINE 和 Cochrane 图书馆中搜索了 2000 年 1 月 1 日至 2020 年 3 月 23 日之间发表的原始系列。我们使用 Cohen 的 kappa 系数来衡量两种模式之间的一致性。我们绘制了分层综合接收者操作特征(HSROC)曲线,并估计了曲线下面积(AUC),以评估两种成像方式在检测严重 MR 方面的一致性。我们确定了 858 项研究,其中 65 项进行了全文评估,8 项纳入了荟萃分析。最终分析共纳入 718 名患者(男性 425 名,占 59%)。在使用的方法和 kappa 系数方面存在显著的异质性,范围从 0.10 到 0.48。八项研究中的七项提供了绘制 HSROC 曲线和计算 AUC 的必要数据。检测严重 MR 的 AUC 为 0.83(95%CI 0.80 至 0.86),而检测中度至重度 MR 的 AUC 为 0.83(95%CI 0.79 至 0.86)。TTE 和 CMR 在整个严重程度分级范围内评估 MR 严重程度的一致性适中。然而,当关注至少中度 MR 的患者时,TTE 和 CMR 之间的一致性非常好。需要进一步的前瞻性研究,比较基于 CMR 和 TTE 评估的 MR 严重程度的硬临床终点。

相似文献

1
Evaluation of mitral regurgitation by cardiac magnetic resonance and transthoracic echocardiography: a systematic review and meta-analysis.心脏磁共振和经胸超声心动图评估二尖瓣反流:系统评价和荟萃分析。
Rev Cardiovasc Med. 2021 Dec 22;22(4):1513-1521. doi: 10.31083/j.rcm2204155.
2
Quantitative assessment of primary mitral regurgitation using left ventricular volumes obtained with new automated three-dimensional transthoracic echocardiographic software: A comparison with 3-Tesla cardiac magnetic resonance.应用新型自动化三维经胸超声心动图软件测量左心室容积对原发性二尖瓣反流的定量评估:与 3.0T 心脏磁共振的比较。
Arch Cardiovasc Dis. 2018 Aug-Sep;111(8-9):507-517. doi: 10.1016/j.acvd.2017.10.008. Epub 2018 Mar 31.
3
Grading mitral regurgitation using 4D flow CMR: Comparison to transthoracic echocardiography.使用 4D 流心脏磁共振对二尖瓣反流进行分级:与经胸超声心动图的比较。
Echocardiography. 2022 Jun;39(6):783-793. doi: 10.1111/echo.15364. Epub 2022 May 10.
4
Meta-Analysis of Transthoracic Echocardiography Versus Cardiac Magnetic Resonance for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Implantation.经导管主动脉瓣置换术后主动脉瓣反流评估的经胸超声心动图与心脏磁共振的荟萃分析。
Am J Cardiol. 2019 Oct 15;124(8):1246-1251. doi: 10.1016/j.amjcard.2019.07.036. Epub 2019 Aug 2.
5
Quantification of mitral regurgitation using transthoracic echocardiography and cardiac magnetic resonance imaging.经胸超声心动图和心脏磁共振成像对二尖瓣反流的定量分析。
Rev Cardiovasc Med. 2021 Mar 30;22(1):215-223. doi: 10.31083/j.rcm.2021.01.20216.
6
Comparative Assessment of Mitral Regurgitation Severity by Transthoracic Echocardiography and Cardiac Magnetic Resonance Using an Integrative and Quantitative Approach.经胸超声心动图和心脏磁共振成像采用综合定量方法对二尖瓣反流严重程度的比较评估
Am J Cardiol. 2016 Jan 15;117(2):264-70. doi: 10.1016/j.amjcard.2015.10.045. Epub 2015 Nov 6.
7
Validation of Semiautomated Quantification of Mitral Valve Regurgitation by Three-Dimensional Color Doppler Transesophageal Echocardiography.三维彩色多普勒经食管超声心动图对半自动化二尖瓣反流定量的验证。
J Am Soc Echocardiogr. 2020 Mar;33(3):342-354. doi: 10.1016/j.echo.2019.10.013.
8
Cardiac Magnetic Resonance Imaging Versus Transthoracic Echocardiography for Prediction of Outcomes in Chronic Aortic or Mitral Regurgitation.心脏磁共振成像与经胸超声心动图在预测慢性主动脉瓣或二尖瓣反流结局中的比较
Am J Cardiol. 2017 Apr 1;119(7):1074-1081. doi: 10.1016/j.amjcard.2016.12.017. Epub 2017 Jan 5.
9
Cardiac magnetic resonance assessment of mitral regurgitation severity appears better than echocardiographic imaging.心脏磁共振评估二尖瓣反流严重程度似乎优于超声心动图成像。
Int J Cardiovasc Imaging. 2020 May;36(5):889-897. doi: 10.1007/s10554-020-01772-1. Epub 2020 Feb 3.
10
Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography.前瞻性比较心脏磁共振成像和经胸超声心动图对瓣膜反流定量的评估。
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):48-57. doi: 10.1161/CIRCIMAGING.112.975623. Epub 2012 Dec 4.

引用本文的文献

1
The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral Regurgitation.心血管磁共振成像在二尖瓣反流评估中的作用。
Diagnostics (Basel). 2024 Mar 19;14(6):644. doi: 10.3390/diagnostics14060644.